BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 2002

View Archived Issues

New migraine therapy available for prescribing in the U.K.

Read More

NeuroSearch signs with development partner for NS-2330

Read More

New neuroscience company formed by Immune Network

Read More

Argatroban reduces stroke-associated mortality in HIT patients

Read More

Beneficial effects and safety demonstrated for gpIIb/IIIa antagonist in acute ischemic stroke

Read More

Field administration of MgSO4 feasible and safe in acute stroke

Read More

Phase II trial of CeaVac and TriAb initiated in metastatic colorectal cancer

Read More

Nutrition 21 identifies isomer of CLA that improves glucose metabolism without insulin

Read More

Orally administered S-23906-1 evaluated for activity in metastatic colon cancer models

Read More

Bracco licenses noninvasive Down's syndrome diagnostic test

Read More

DFB to evaluate Demegen's D2A21 antimicrobial gel with option to license

Read More

Scios reviews 2001 achievements, plans for 2002

Read More

Combination of 2-methoxyestradiol with oxidative stress associated with enhanced antitumor activity

Read More

Silico Insights and Genzyme Molecular Oncology enter oncogenic collaboration

Read More

Tracleer fails to meet primary endpoints in phase III CHF study

Read More

Pharmacia discontinues SU-5416 clinical program

Read More

Toxicology studies completed for Reolysin

Read More

Study finds fluvastatin is not associated with creatine kinase elevation

Read More

Hormone therapy more likely to improve quality of life in women with flushing

Read More

Indole derivatives as ligands of dopamine D4 and 5-HT2A receptors

Read More

Pyrazole derivatives prepared at DuPont for thromboembolic disorders

Read More

Antibacterial compounds that act as fatty acid synthase FabH inhibitors

Read More

Letrozole superior to anastrozole in reducing estrogen production in breast cancer patients

Read More

Selective ligands of nicotinic alpha4beta2 receptors claimed for treatment of memory disorders

Read More

Weight loss and exercise more effective than metformin in delaying the onset of diabetes

Read More

Pfizer claims glycine derivatives in treatment of mood disorders

Read More

Pamoic acid derivatives for Alzheimer's disease presented by Sigma-Tau

Read More

Eptifibatide protects patients one year after coronary stent implantation

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing